Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
6.28
-0.06 (-0.95%)
At close: Feb 13, 2026, 4:00 PM EST
6.24
-0.04 (-0.64%)
After-hours: Feb 13, 2026, 7:54 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Antibody-Based Therapeutics
850.00K

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
850.00K